Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spain: rise in COPD (chronic obstructive pulmonary disease) hides major underdiagnosis

This article was originally published in Clinica

Executive Summary

Spanish pneumology experts are calling for better detection of chronic obstructive pulmonary disease (COPD), amid evidence that only one of five cases is diagnosed. The incidence of COPD has risen significantly in Spain in recent years. It currently affects 9.2% of the population aged 40-69 years, accounting for 7% of all hospital admissions and 2% of the overall healthcare budget. However, a recent study found that 78.2% of cases were undiagnosed and that more than half of all cases classed as severe were not being treated.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT058031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel